NCT03832751Unknown不适用
Estimation of Tissue Level of Human Beta-defensin 1 (HBD-1) in Vitiligo Before and After Narrowband UVB Phototherapy: a Case-control Study
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 25
- 主要终点
- Tissue levels of human beta-defensin 1 before and after NB-UVB phototherapy
研究概览
简要总结
There is a need to know the role of human beta defensin-1 in vitiligo pathogenesis and the probability of finding newer and effective therapy for vitiligo in the future.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with non-segmental vitiligo.
- •Both genders.
- •Age more than 18 years old.
- •New cases or cases not receiving any treatment for at least 3 months prior to the study.
排除标准
- •Universal or segmental vitiligo.
- •Any contraindication to phototherapy treatment.
- •History of autoimmune diseases or other systemic diseases.
- •Any other skin disease.
结局指标
主要结局
Tissue levels of human beta-defensin 1 before and after NB-UVB phototherapy
时间窗: 6 months to 1 year
次要结局
未报告次要终点
研究者
Maha Fathy Elmasry
principal investigator
Cairo University
相似试验
Unknown
不适用
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?Bullous PemphigoidNCT03636763Assistance Publique Hopitaux De Marseille183
已完成
2 期
Hepatitis B Vaccination (HBV) in HIV Infected ChildrenHIV InfectionsNCT00886964The HIV Netherlands Australia Thailand Research Collaboration80
尚未招募
不适用
Serum Elafin and Vascular Affection in Behcet DiseaseBehcet Disease and Vascular AffectionNCT06272929Assiut University90
已完成
不适用
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)Recessive Dystrophic Epidermolysis BullosaNCT01874769Institut National de la Santé Et de la Recherche Médicale, France30
已完成
不适用
Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease ActivityBehcet SyndromeNCT06729112Assiut University80